GlassScriptPhysician profile
Nayan C Shah
NPI 1982799664
$2,166.64
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $814 · 2020: $367 · 2021: $377 · 2022: $516 · 2024: $91.69.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $91.69.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $91.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $347.32 | 2019-2022 | |
| Janssen Biotech, INC. | $319.27 | 2019-2022 | |
| Gilead Sciences, INC. | $260.57 | 2019-2022 | |
| Celgene Corporation | $157.66 | 2021-2022 | |
| Pfizer INC. | $144.98 | 2019-2021 | |
| Boston Scientific Corporation | $111.58 | 2019 | |
| Intercept Pharmaceuticals, INC. | $99.41 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $95.02 | 2019-2020 | |
| Pulmonx Corporation | $91.69 | 2024 | Zephyr Endobronchial Valve, Zephyr Delivery Catheter, Chartis Catheter |
| Eisai INC. | $89.84 | 2020 | |
| Janssen Scientific Affairs, LLC | $86.63 | 2019 | |
| Biofire Diagnostics, LLC | $66.54 | 2019 | |
| Ironwood Pharmaceuticals, INC | $65.04 | 2020-2022 | |
| Alfasigma USA, INC. | $51.26 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $50.88 | 2019-2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Braintree Laboratories, INC. | $26.66 | 2021 | |
| Merck Sharp & Dohme LLC | $24.26 | 2022 | |
| Ardelyx, INC. | $23.17 | 2022 | |
| Qol Medical, LLC | $19.49 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $12.85 | 2022 | |
| Allergan, INC. | $11.47 | 2019 | |
| Shionogi INC | $11.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nayan Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.